BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33481211
Number of visits today
8599
Number of downloads
16667456
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Zeng R, Zhuo Z, Luo Y, Sha W, Chen H. Rho GTPase signaling in rheumatic diseases. iScience 2022;25:103620. [PMID: 35005558 DOI: 10.1016/j.isci.2021.103620] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Adhikari UK, Khan R, Mikhael M, Balez R, David MA, Mahns D, Hardy J, Tayebi M. Therapeutic anti-amyloid β antibodies cause neuronal disturbances. Alzheimers Dement 2022. [PMID: 36515320 DOI: 10.1002/alz.12833] [Reference Citation Analysis]
2 Papadopoulou D, Roumelioti F, Tzaferis C, Chouvardas P, Pedersen A, Charalampous F, Christodoulou-vafeiadou E, Ntari L, Karagianni N, Denis M, Olsen J, Matralis A, Kollias G. Repurposing of Amisulpride, a known antipsychotic drug, to target synovial fibroblasts activation in arthritis.. [DOI: 10.1101/2022.08.02.500956] [Reference Citation Analysis]
3 Murphy EP, Crean D. NR4A1-3 nuclear receptor activity and immune cell dysregulation in rheumatic diseases. Front Med 2022;9. [DOI: 10.3389/fmed.2022.874182] [Reference Citation Analysis]
4 Sauzeau V, Beignet J, Bailly C. Rac1 as a Target to Treat Dysfunctions and Cancer of the Bladder. Biomedicines 2022;10:1357. [PMID: 35740379 DOI: 10.3390/biomedicines10061357] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345